Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Choi, Hyo-Kyoung  [Clear All Filters]
2024
Lee S-H, Lim G, Kim H, Suh D, Choi H-K, Kim H-P, Yoon H-G, Park SWook, Kang S-M, Kwon C, et al. Generation of an induced pluripotent stem cell line from a patient with arrhythmogenic right ventricular cardiomyopathy harboring a TMEM43 splice-site variant. Stem Cell Res. 2024;78:103453.
Song J-H, Kim M-S, Lee S-H, Hwang J-T, Park S-H, Park SWook, Jeon S-B, Lee R-R, Lee J, Choi H-K. Hydroethanolic extract of Cirsium setidens ameliorates doxorubicin-induced cardiotoxicity by AMPK-PGC-1α-SOD-mediated mitochondrial protection. Phytomedicine. 2024;129:155633.
2022
Kim H, Kim H-J, Oh J, Lee S-T, Won D, Choi H-K, Choi JRak, Kim S, Kim H-P, Kim S-J, et al. An induced pluripotent stem cell line (YCMi006-A) generated from a patient with hypertrophic cardiomyopathy who carries the ACTA1 mutation p.Ile343Met. Stem Cell Res. 2022;63:102874.
2021
Oh J, Lee S-H, Choi J, Choi JRak, Kim S, Cha Y-J, Choi H-K, Won D, Yoon H-G, Park SWook, et al. Establishment of a novel human iPSC line (YCMi003-A) from a patient with dilated cardiomyopathy carrying genetic variant LMNA p.Asp364His. Stem Cell Res. 2021;56:102508.
Lee S-H, Oh J, Lee S-T, Won D, Kim S, Choi H-K, Kim S-J, Han H, Yoon M, Choi JRak, et al. Generation of a human induced pluripotent stem cell line YCMi004-A from a patient with dilated cardiomyopathy carrying a protein-truncating mutation of the Titin gene and its differentiation towards cardiomyocytes. Stem Cell Res. 2021;59:102629.